1/ Why is carboplatin the only chemotherapy we dose by AUC?
A short tweetorial brought to you from a question posed by @FreedoBaggins.
Bottom Line: Chemo is Cool!
#MedEd #HemeTwitter
A short tweetorial brought to you from a question posed by @FreedoBaggins.
Bottom Line: Chemo is Cool!
#MedEd #HemeTwitter
2/ What is AUC (Area under the curve)?
Mathematically it is the âintegral of a curve describing variation of drug concentration over timeâ
Perhaps more helpfully, it functionally describes total drug exposure over time

Perhaps more helpfully, it functionally describes total drug exposure over time
3/ For almost all chemotherapy agents, you would ideally want to dose by AUC if you could.
Most chemotherapy toxicities are proportional to (drug concentration
time), which makes sense: higher concentration -> longer itâs around -> more toxicities.
Most chemotherapy toxicities are proportional to (drug concentration

4/ But truly calculating AUC requires multiple data points of drug concentrations at various time points. How is it that we can estimate the AUC of a drug without checking drug concentrations? What is special about carboplatin that lets us do it literally every day?
5/ Carboplatin is the only chemotherapy that is cleared entirely by glomerular filtration.
liver metabolism
renal secretion
renal absorption
Therefore, you can reliably predict its AUC from a single bolus dose based on a patientâs GFR.



Therefore, you can reliably predict its AUC from a single bolus dose based on a patientâs GFR.
6/ When all is said and done, if you want an AUC of 6 (a common target dose), you can use the empirically-derived Calvert formula:
Total carboplatin dose in mg = Target AUC (mg*min/ml) x (estimated creatinine clearance + 25) mg/min. The units work out. https://pubmed.ncbi.nlm.nih.gov/2681557/
Total carboplatin dose in mg = Target AUC (mg*min/ml) x (estimated creatinine clearance + 25) mg/min. The units work out. https://pubmed.ncbi.nlm.nih.gov/2681557/
7/ Interesting Historical Notes:
When carboplatin was first developed in 1981, it was dosed based upon BSA like most other chemo (400mg/m2). This resulted in the significant mis-dosing (both over- and under-) of many patients.
When carboplatin was first developed in 1981, it was dosed based upon BSA like most other chemo (400mg/m2). This resulted in the significant mis-dosing (both over- and under-) of many patients.